Gene regulatory networks analysis of muscle-invasive bladder cancer subtypes using differential graphical model
Abstract Background Recently, erdafitinib (Balversa), the first targeted therapy drug for genetic alteration, was approved to metastatic urothelial carcinoma. Cancer genomics research has been greatly encouraged. Currently, a large number of gene regulatory networks between different states have bee...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1d67f4700f7a45789b9f3f6ba0db20b3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|